What is Gaucher Disease?Presence of a Buildup of Fatty SubstancesGaucher disease is a rare inherited disorder that results from the buildup of fatty substances called glycolipids in certain cells within the body. This buildup is caused by a deficiency in the enzyme glucocerebrosidase, which normally breaks down these fatty substances. The buildup causes damage and dysfunction in these cells,...

Pfizer and Protalix BioTherapeutics have gotten endorsement from the US Food and Medication Administration (FDA) for Elelyso (taliglucerase alfa) to treat pediatric patients with type 1 Gaucher disease. Elelyso will be provided in the type of injection for pediatric patients. Pfizer worldwide medical affairs and worldwide innovative pharma business senior vice-president Rory Connor said: "The...